There were no significant differences in any serum cytokine levels between groups except for higher levels of IL-8 in CF at baseline and post-CFTR modulators compared to non-CF (Fig. 5F), and higher IL-12 production in CF patients on ivacaftor compared to no treatment (Fig. 5D). The gene discussed is CXCL8; the disease is cystic fibrosis.